A Smart Pill for Insulin?

[1]	Centers for Disease Control and Prevention. National diabetes statistics report, 2017. Atlanta: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2017.

[2]	World Health Organization China Office. Rate of diabetes in China ‘‘explosive”: healthy diet and exercise key to turning the tide [Internet]. Manila: WHO Western Pacific Office; 2016 Apr 6 [cited 2019 June 16]. Available from: http:// www.wpro.who.int/china/mediacentre/releases/2016/20160406/en/.

[3]	Oleck J, Kassam S, Goldman JD. Commentary: why was inhaled insulin a failure in the market? Diabetes Spectr 2016;29(3):180–4.

[4]	Abramson A, Caffarel-Salvador E, Khang M, Dellal D, Silverstein D, Gao Y, et al. An ingestible self-orienting system for oral delivery of macromolecules. Science 2019;363(6427):611–5.

[5]	Lopes CM, Bettencourt C, Rossi A, Buttini F, Barata P. Overview on gastroretentive drug delivery systems for improving drug bioavailability. Int J Pharm 2016;510(1):144–58.

[6]	Fix JA, Cargill R, Engle K. Controlled gastric emptying. III. Gastric residence time of a nondisintegrating geometric shape in human volunteers. Pharm Res 1993;10(7):1087–9.

[7]	Zhang S, Bellinger AM, Glettig DL, Barman R, Lee YA, Zhu J, et al. A pHresponsive supramolecular polymer gel as an enteric elastomer for use in gastric devices. Nat Mater 2015;14(10):1065–71.

[8]	Iddan G, Meron G, Glukhovsky A, Swain P. Wireless capsule endoscopy. Nature 2000;405(6785):417.

[9]	Slawinski PR, Obstein KL, Valdastri P. Emerging issues and future developments in capsule endoscopy. Tech Gastrointest Endosc 2015;17 (1):40–6.

[10]	Schiel R, Bambauer R, Steveling A. Technology in diabetes treatment: update and future. Artif Organs 2018;42(11):1017–27.

[11]	Tan SY, Mei Wong JL, Sim YJ, Wong SS, Mohamed Elhassan SA, Tan SH, et al. Type 1 and 2 diabetes mellitus: a review on current treatment approach and gene therapy as potential intervention. Diabetes Metab Syndr 2019;13 (1):364–72.

[12]	Doiron B, Hu W, DeFronzo RA. Beta cell formation in vivo through cellular networking, integration and processing (CNIP) in wild type adult mice. Curr Pharm Biotechnol 2016;17(4):376–88.

[13]	Jimenez V, Jambrina C, Casana E, Sacristan V, Muñoz S, Darriba S, et al. FGF21 gene therapy as treatment for obesity and insulin resistance. EMBO Mol Med 2018;10(8):e8791.